Skip to main content

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated Cookie policy, Privacy policy and Terms & Conditions

Curated by Project Syndicate

Donald Trump 2.0?

3 commentaries

A recent willingness to cut deals with congressional Democrats, together with the appointment of ex-Marine General John Kelly as White House Chief of Staff, is fueling speculation about the emergence of a new-model Trump. But will his character and anarchic style of governing stand in the way of an effective presidency?

Sort by: Show:
  1. A New Trump?
    Donald Trump walks out of St John's Epicopal Church i Nicholas Kamm/Getty Images

    A New Trump?

    Sep 15, 2017 Elizabeth Drew pours cold water on heated speculation that the White House is finally getting its act together.

    5

Our Pick

op_stiglitz4_SAUL LOEBAFP via Getty Images_covidvaccine Saul Loeb/AFP via Getty Images
Free to read

Will Corporate Greed Prolong the Pandemic?

Joseph E. Stiglitz & Lori Wallach

The US will no longer stand in the way of an international waiver that would allow the production of generic COVID-19 vaccines, but the fight isn't over. And the longer the pharmaceutical industry resists sharing knowledge and technology, the greater the risk posed by the emergence of new vaccine-resistant variants.

dismantle Big Pharma's arguments against waiving intellectual property rights to boost global vaccine production.
28

Featured

  1. op_stiglitz4_SAUL LOEBAFP via Getty Images_covidvaccine Saul Loeb/AFP via Getty Images
    Free to read

    Will Corporate Greed Prolong the Pandemic?

    Joseph E. Stiglitz & Lori Wallach

    The US will no longer stand in the way of an international waiver that would allow the production of generic COVID-19 vaccines, but the fight isn't over. And the longer the pharmaceutical industry resists sharing knowledge and technology, the greater the risk posed by the emergence of new vaccine-resistant variants.

    dismantle Big Pharma's arguments against waiving intellectual property rights to boost global vaccine production.
    28

Edit Newsletter Preferences

Set up Notification

To receive email updates regarding this {entity_type}, please enter your email below.

If you are not already registered, this will create a PS account for you. You should receive an activation email shortly.